Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT07545811 · RECRUITING

Trial details

NCT number: NCT07545811
Sponsor: Janux Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Castration-resistant Prostate Cancer Castration-resistant Prostate Cancer

Start date: 2026-04-15
Primary completion: 2028-05-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.